CS Paper Radar

OpenGray: a benchmark for evaluating the decisions of radiotherapy planning agents

Humza Nusrat, Kundan Thind

cs.AI physics.med-ph ·submitted 2026-10-27 11:42 UTC · v1
benchmark

Abstract

Background and purpose: Radiotherapy planning agents based on large language models (LLMs) decide when to submit a plan or request review but are evaluated mainly by dose. This study developed OpenGray, a benchmark of planning tasks with known correct decisions. Materials and methods: OpenGray adds tasks with known answers to the OpenKBP-Opt head-and-neck dataset, including two contradictions with dose goals proven incompatible and a feasible control with a stored plan meeting every hard goal. Four systems, from a rule-based planning script to a full LLM agent, were evaluated on 30 patients, the LLM-based ones with a commercial (Terra) and a local (Ministral 3 8B) LLM. Decisions, achieved dose, problem recognition, and technical failures were recorded and also read from logs of 39 stereotactic radiosurgery runs of SAGE, a clinical LLM agent. Results: With Terra, the script preceded by an LLM review and the full agent had decision accuracies of 95.4% and 92.1%, respectively, yet escalated only 50% (95% confidence interval, 25-75%) and 25% (10-40%) of overlap contradictions, which required arithmetic on the anatomy. All four systems submitted every feasible control, but 24% of these plans missed a hard goal that the stored plan had met. In four SAGE runs, one goal failed at every attempt; the agent identified it in every reply but had no action for stopping. Conclusions: Favorable aggregate scores concealed specific decision failures. Planning agents should be evaluated on their decisions as well as their dose and given an explicit action for stopping and requesting review.

Comment
25 pages, 4 figures, 1 table, and the supplementary material (19 tables, 5 figures). Ancillary files: the paper in Markdown, structured results with the sentence each comes from, and an llms.txt index for AI agents

Closest papers

Nearest neighbours by meaning across the whole index.

An Evidence-Driven Multi-Agent Compound AI System for Head and Neck Proton Radiotherapy Planning

cs.AI ·2026-10-21 ·Qingqing Wang, Liqiang Xiao, Chang Chang
similarity 0.67
Abstract

Radiation treatment planning requires balancing competing objectives to satisfy clinical criteria while accommodating physicians' preferences. This study aims to develop an evidence-driven, multi-agent compound AI system that integrates DRL-based automated treatment planning with LLM-based conversational plan refinement for proton PBS therapy. A policy network trained using PPO first generates multiple plans without human intervention, from which one is selected as the target plan and the others serve as references for subsequent refinements. For challenging cases requiring further adjustments, an LLM-based multi-agent system enables plan refinement through natural language interactions. The system comprises a planning agent that recommends evidence-supported adjustments, a chatbot providing a unified conversational interface, and an evaluation agent that retrieves clinical metrics and identifies constraint violations. To enhance domain-specific reasoning, the planning agent based on Qwen3-14B is designed to justify its recommendations using evidence from previously generated plans and post-trained on task-specific data using SFT and GRPO. The framework was trained and evaluated using 21 patients with H&N cancers, with 5 PPO-generated plans per patient. Of these, 50 plans were selected for instruction-guided refinement. Compared with the base LLM, the post-trained Qwen3-14B demonstrated improved instruction-following, information retrieval and domain-specific reasoning capabilities. The resulting adjustments more effectively improved user-prioritized objectives while limiting deterioration in competing objectives, yielding more clinically appropriate trade-offs in patient-specific plan refinement. The proposed compound AI system provides a user-friendly planning platform, offering a promising approach to personalized proton PBS treatment planning.

0.11

Safeguarding Agentic AI in Radiology Workflows: A Multimodel Evaluation of Rule-based and Large Language Model-based Verification

cs.AI cs.CLcs.CY ·2026-11-08 ·Semil Eminovic, Robin Schmidt, Bogdan Levita, Maximilian Lindholz, Tobias Penzkofer +1 more
code/data similarity 0.61
Abstract · 43 pages, 6 figures, 4 tables, supplementary material included. Tobias Penzkofer and Jawed Nawabi share last authorship. Code: https://githu…

Purpose: To estimate how often tool-using large language model (LLM) agents record clinically relevant false or unsupported information in simulated radiology documentation and how much safeguards applied before each action reduce these errors. Materials and Methods: In this simulation study (October 2026), 48 synthetic, radiologist-reviewed base scenarios covered finding communication, tumor board preparation and follow-up management. Forty-three also had a misleading-information variant (91 variants). Six LLM agents (Claude Sonnet 5.5, GPT-6.1-Sol, GLM-5.3, MiniMax M3, Gemma-4-31B, Qwen3.8-27B) completed each variant with permissions only, deterministic rules, and rules plus a locally run LLM checker (1638 episodes). The primary outcome was at least one executed high-severity violation per episode. Risk differences were estimated per agent at base-scenario level and, exploratorily, pooled across agents, with analyses of document access and blocks. Results: With permissions only, 7.3%-27.1% of episodes had a high-severity violation (pooled across agents, 19.4%). Pooled, it was 16.7% with rules (-2.8 percentage points; 95% CI: -6.1, 0.5) and 13.2% with rules plus the LLM checker (-6.2; 95% CI: -9.5, -3.0). Adding the LLM checker to rules changed it by -3.5 (95% CI: -6.3, -0.7). No difference between agents was detected (P = .43), and task success did not decrease detectably. In misleading variants, agents opened the altered document in 83% of episodes regardless of error, and 58% of erroneous statements cited it. Most blocked actions (64%-68%) would not have caused a violation and were returned for revision. Conclusion: Layered safeguards reduced but did not prevent high-severity errors. Errors after misleading information reflected misjudged rather than missed information.

0.41

Supervision-Aware Evaluation of MedGemma for Reference-Assisted Radiotherapy Contour Ranking

eess.IV cs.CVcs.LG ·2026-11-11 ·Jaden Moon, Caiwen Jiang, Songlin Zhao, Wei Liu
similarity 0.59
Abstract · 5 pages, 1 figure, 3 tables. Submitted to IEEE ISBI 2027

Radiotherapy contour ranking can support quality assurance, but vision-language model (VLM) gains may reflect supervision, score construction, available inputs, or representation access. We evaluated frozen MedGemma 1.5 in a single-institution study, a 12-patient held-out HaN-Seg test, five-fold cross-fitting on 30 non-test HaN-Seg patients, and transfer without refitting to 120 SegRap2023 patients. On held-out HaN-Seg, a supervised readout of the final prompt state exceeded a supervised readout of the model's yes/no output probabilities by +0.3047 pooled average precision (AP; 95% patient-bootstrap interval [+0.2822, +0.3269]); the advantage persisted against a parameter-count-matched nonlinear control. A readout of projected visual tokens exceeded the final-state readout in cross-fitting and transfer (+0.0706 AP averaged equally across patients on SegRap; 95% interval [+0.0607, +0.0804]), while a structured panel-feature readout remained competitive with visual tokens. The anatomy-conditioned readout did not demonstrate an advantage over the native-feature comparator. These results motivate visual-token and structured-feature controls in medical-imaging VLM evaluations; outcomes were computational or synthetic, not clinical acceptability.

0.22

Dose-PlanNet: Physics Based Radiotherapy Dose Prediction with Deep Learning

cs.CV physics.med-phcs.LG ·2026-08-27 ·Ankit Bhattacharjee, Sougata Maity, Santam Chakraborty, Indranil Mallick
code/data similarity 0.59
Abstract · The paper consists of 22 pages, 4 figures, 6 tables. The end-to-end pipeline of Dose-PlanNet will soon be made available on the GitHub repos…

Automating prostate radiotherapy treatment planning is dosimetrically complex, particularly for extreme hypofractionated regimens. In this study, we introduce Dose-PlanNet, a physics-guided 3D deep learning architecture designed to predict dose distributions. This model's performance was evaluated on a cohort of patients treated in a prospective trial where two different dose fractionation regimens were employed. Dose-PlanNet achieved comparable target coverage ($D_{95}$), though statistical analysis revealed a marginal reduction in target homogeneity ($p<0.001$) offset. However the model achieved statistically significant improvements in high-dose organ-at-risk sparing ($p<0.001$). When evaluated against strict Prospective Randomized protocol volumetric constraints, automated plans met prespecified clinical acceptance criteria in $11$ out of $14$ Moderate Hypofraction Arm plans and $9$ out of $12$ Stereotactic Body Radiation Therapy Arm plans. This pipeline demonstrates that physics-informed deep learning can accelerate radiotherapy workflows while safely maintaining the stringent dosimetric quality required for high-precision clinical deployment.

0.36

RadOnc-Agent: An Integrated Framework for AI Workflows Across the Radiotherapy Care Pathway

cs.AI ·2026-10-02 ·Caiwen Jiang, Shuoyang Wei, Songlin Zhao, Junyu Li, Jingyuan Chen +6 more
similarity 0.56
Abstract

Artificial intelligence has advanced radiotherapy tasks, but these capabilities remain fragmented across the care pathway. Here we present RadOnc-Agent, an integrated framework connecting 17 phase-specific functions and 9 cross-cutting utilities across four phases through a conversational interface. A language-model controller maps clinical intent to structured calls, maintains longitudinal context and validates dispatch. We evaluated request-expression diversity, function coverage, cross-stage composition, information transfer and failure recovery using 2,600 single-function requests (7,800 executions), 200 cross-stage scenarios (600 executions), and 120 workflows from 60 de-identified patient records (360 executions). RadOnc-Agent selected the intended function in 98.79% of single-function executions and completed 96.50% of scripted and 96.67% of real-patient workflows. Removing longitudinal state reduced cross-stage completion from 96.50% to 84.00%; bypassing schema and identity validation increased mismatched dispatch from 0% to 95.28% in replay/test execution. Single-function performance did not by itself predict workflow-level capability. Information continuity and cross-stage dependencies emerged as central constraints. These results establish the technical feasibility of longitudinal integration across radiotherapy workflows and provide a foundation for prospective clinical evaluation.

0.17

Transformer-Based Reinforcement Learning for Phase I Dose Allocation

cs.LG stat.MLstat.AP ·2026-10-30 ·Shijie Yuan
similarity 0.56
Abstract

Phase I dose-finding trials must learn from sparse toxicity observations while limiting exposure to overly toxic doses. We develop a single reinforcement-learning policy for trials with different numbers of ordered dose levels. Each dose is represented as a token containing its normalized position, accumulated patient count, observed dose-limiting toxicities (DLTs), and current-dose indicator. A Transformer encoder summarizes the dose tokens, trial-conditioned cross-attention produces a fixed-dimensional trial representation, and a three-action policy chooses de-escalation, staying, or escalation. The final maximum tolerated dose (MTD) decision is deliberately kept outside the learned policy: after the planned sample size, weighted isotonic regression and a prespecified safety cap select the dose closest to the target toxicity probability. In the simulations, toxicity-penalized policies reduce DLT burden while unpenalized policies improve selection accuracy at the cost of greater toxicity. These results demonstrate a controllable safety--accuracy trade-off but do not establish superiority over conventional dose-finding designs.

0.16

TrialDesignBench: Benchmarking Language Models for Phase-I Trial Design Against Clinical Knowledge

cs.AI cs.CLstat.AP ·2026-11-09 ·Yihan Hank Tang, Peng Yang, Jiayi Xin, Tianqi Shang, Xuyang Chen +3 more
publishedbenchmarkcode/data similarity 0.55
Abstract · 13 pages, 3 figures, 6 tables. Presented as a poster at the NeurIPS 2026 Workshop on World Models for High-Stakes Health (WMHS). Code and da…

AI is used in much of the clinical trial pipeline. However, selecting the statistical design of a trial, a crucial step that determines how drug doses are tested on humans and evaluated, has seen almost no AI progress. LLMs appear to be a natural fit given their strengths in biomedical knowledge and statistical reasoning. Nevertheless, there is currently no appropriate way to evaluate such abilities because recent regulatory and methodological shifts, most notably FDA's Project Optimus, have redefined what constitutes a reasonable design and rendered many previous designs obsolete. To lay the groundwork for AI-assisted trial design, we introduce TrialDesignBench, a benchmark of 617 Phase-I/I-II oncology dose-finding trials, each paired with an expert-validated reference design that is consistent with the latest FDA regulatory initiatives. This reference standard is produced through a formalization of the expert design process. We evaluate five frontier LLMs, none of which matches the reference standard. Our ablation experiments trace this performance gap to two main causes, inference of latent, unrecorded design determinants from trial sources (supplying them raises class-wise balanced accuracy by 0.22) and structured decision-tree reasoning (+0.24). TrialDesignBench offers a reproducible, contemporary-standard objective for evaluating and enhancing AI-assisted trial design.

0.55

AgentJudgeBench: A Multi-Difficulty Benchmark for Evaluating LLM Judges on Agentic Tool-Calling

cs.AI ·2026-08-27 ·Abhigya Verma, Amit Kumar Saha, Seganrasan Subramanian, Sai Harshitha Aluru
top venuebenchmarkhighly cited similarity 0.54
Abstract · 31 Pages, 9 Figures, 31 Tables, Accepted as a main conference paper at EMNLP 2026

LLM judges are widely used to evaluate agentic tool-calling systems, yet their reliability on structured, dependency-driven workflows remains largely unexamined. We present AgentJudgeBench, the first benchmark to systematically study LLM-as-a-judge reliability for agentic tool-calling over workflow DAGs, as distinct from the broader LLM-as-a-judge task of open-ended text or preference evaluation. The benchmark comprises 3,808 instances spanning six DAG topologies and three difficulty tiers, evaluated with five generators (3B-70B open-weight models and GPT-5.4) and six judges (20B to frontier scale) under paired with- and without-ground-truth conditions. Judge alignment degrades monotonically with task difficulty, 1.5x faster without ground truth, and on hard queries without ground truth all six judges converge to a narrow 77-82% band regardless of scale, revealing a structural ceiling driven primarily by task difficulty, though its height is partly prompt-dependent for weaker generators, that model capacity alone cannot overcome. Ground-truth exposure is not uniformly beneficial: it reduces alignment for GPT-5.4 (1.5 pp) and Gemini-2.5-Pro (3.9 pp), consistent with over-anchoring. Among mitigation strategies, chain-of-thought reasoning and judge temperature both have negligible effect, while structured evaluation rubrics improve alignment by up to 6.5 pp but do not generalize uniformly across judge-generator pairs. With ground truth, QwQ-32B best matches the programmatic reference, while a human validation study identifies GPT-OSS-120B as the most human-aligned judge; without it, frontier judges lead only marginally within the shared ceiling. These results expose fundamental limitations of current LLM judges and yield practical guidelines for reliable evaluation in agentic systems.

0.69